CORDLIFE GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.129 SGD | +3.20% |
|
+4.88% | -59.05% |
| Apr. 18 | Cordlife Group Lodges Police Report Against Former Staff Over Cryogenic Tank Incident | MT |
| Apr. 17 | Cordlife Enters Subscription Agreements | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Cordlife Group Limited is a Singapore-based company that owns cord blood banks in Asia with full stem cell banking facilities in Singapore, Hong Kong, Indonesia, the Philippines, India and Malaysia. The Companyâs segments include Banking and Diagnostics. The banking segment comprises the collection, processing and banking of biological materials. The diagnostics segment comprises diagnostics testing services. Its banking services include cord blood, cord lining, cord lining mesenchymal stem cells, corneal lenticule, cord lining epithelial stem cells, cord tissue and others. Its diagnostic testing services include newborn genetic screening, pediatric vision screening, pediatric ear screening, pediatric allergen test, genetic talent test, preimplantation genetic screening, endometrial receptivity test, non-invasive prenatal testing and newborn metabolic screening. Its MOMS UP is a mobile app offering pregnancy, as well as parenting resources for moms and moms-to-be in Asia.
Calendar
2024-05-09
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -59.05% | 24.26M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- P8A Stock
- News Cordlife Group Limited
- Cordlife Group’s Attributable Profit Halves as Company Battles Legal Issues; Shares Slump 9%
